GO:0003678 | DNA helicase activity | 1.15e-04 | 1.00e+00 | 6.914 | 2 | 3 | 18 |
GO:0032508 | DNA duplex unwinding | 5.22e-04 | 1.00e+00 | 5.836 | 2 | 5 | 38 |
GO:0005654 | nucleoplasm | 5.32e-04 | 1.00e+00 | 2.631 | 5 | 55 | 876 |
GO:0031100 | organ regeneration | 7.00e-04 | 1.00e+00 | 5.624 | 2 | 2 | 44 |
GO:0004151 | dihydroorotase activity | 9.22e-04 | 1.00e+00 | 10.083 | 1 | 1 | 1 |
GO:0004070 | aspartate carbamoyltransferase activity | 9.22e-04 | 1.00e+00 | 10.083 | 1 | 1 | 1 |
GO:0004088 | carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity | 9.22e-04 | 1.00e+00 | 10.083 | 1 | 1 | 1 |
GO:0070335 | aspartate binding | 9.22e-04 | 1.00e+00 | 10.083 | 1 | 1 | 1 |
GO:0070409 | carbamoyl phosphate biosynthetic process | 9.22e-04 | 1.00e+00 | 10.083 | 1 | 1 | 1 |
GO:0005681 | spliceosomal complex | 1.09e-03 | 1.00e+00 | 5.302 | 2 | 2 | 55 |
GO:0071013 | catalytic step 2 spliceosome | 1.34e-03 | 1.00e+00 | 5.153 | 2 | 5 | 61 |
GO:0030953 | astral microtubule organization | 1.84e-03 | 1.00e+00 | 9.083 | 1 | 1 | 2 |
GO:0000022 | mitotic spindle elongation | 1.84e-03 | 1.00e+00 | 9.083 | 1 | 1 | 2 |
GO:0016363 | nuclear matrix | 1.92e-03 | 1.00e+00 | 4.894 | 2 | 7 | 73 |
GO:0016020 | membrane | 2.35e-03 | 1.00e+00 | 2.168 | 5 | 38 | 1207 |
GO:0000278 | mitotic cell cycle | 2.39e-03 | 1.00e+00 | 3.374 | 3 | 35 | 314 |
GO:0005730 | nucleolus | 2.44e-03 | 1.00e+00 | 2.156 | 5 | 41 | 1217 |
GO:0006543 | glutamine catabolic process | 2.76e-03 | 1.00e+00 | 8.499 | 1 | 1 | 3 |
GO:0044205 | 'de novo' UMP biosynthetic process | 2.76e-03 | 1.00e+00 | 8.499 | 1 | 1 | 3 |
GO:0006207 | 'de novo' pyrimidine nucleobase biosynthetic process | 2.76e-03 | 1.00e+00 | 8.499 | 1 | 1 | 3 |
GO:0000086 | G2/M transition of mitotic cell cycle | 3.36e-03 | 1.00e+00 | 4.484 | 2 | 5 | 97 |
GO:0042802 | identical protein binding | 3.37e-03 | 1.00e+00 | 3.201 | 3 | 7 | 354 |
GO:0051414 | response to cortisol | 3.68e-03 | 1.00e+00 | 8.083 | 1 | 1 | 4 |
GO:0000212 | meiotic spindle organization | 3.68e-03 | 1.00e+00 | 8.083 | 1 | 1 | 4 |
GO:0006228 | UTP biosynthetic process | 3.68e-03 | 1.00e+00 | 8.083 | 1 | 1 | 4 |
GO:0001940 | male pronucleus | 3.68e-03 | 1.00e+00 | 8.083 | 1 | 1 | 4 |
GO:0014075 | response to amine | 4.60e-03 | 1.00e+00 | 7.762 | 1 | 1 | 5 |
GO:0005827 | polar microtubule | 4.60e-03 | 1.00e+00 | 7.762 | 1 | 1 | 5 |
GO:0000930 | gamma-tubulin complex | 4.60e-03 | 1.00e+00 | 7.762 | 1 | 1 | 5 |
GO:0001939 | female pronucleus | 4.60e-03 | 1.00e+00 | 7.762 | 1 | 1 | 5 |
GO:0003924 | GTPase activity | 5.01e-03 | 1.00e+00 | 4.189 | 2 | 3 | 119 |
GO:0046134 | pyrimidine nucleoside biosynthetic process | 5.52e-03 | 1.00e+00 | 7.499 | 1 | 1 | 6 |
GO:0031000 | response to caffeine | 5.52e-03 | 1.00e+00 | 7.499 | 1 | 1 | 6 |
GO:0042555 | MCM complex | 5.52e-03 | 1.00e+00 | 7.499 | 1 | 1 | 6 |
GO:0022027 | interkinetic nuclear migration | 5.52e-03 | 1.00e+00 | 7.499 | 1 | 1 | 6 |
GO:0005515 | protein binding | 5.67e-03 | 1.00e+00 | 1.074 | 8 | 76 | 4124 |
GO:0000398 | mRNA splicing, via spliceosome | 5.78e-03 | 1.00e+00 | 4.083 | 2 | 8 | 128 |
GO:0006184 | GTP catabolic process | 5.96e-03 | 1.00e+00 | 4.061 | 2 | 3 | 130 |
GO:0010389 | regulation of G2/M transition of mitotic cell cycle | 6.44e-03 | 1.00e+00 | 7.276 | 1 | 1 | 7 |
GO:0033762 | response to glucagon | 6.44e-03 | 1.00e+00 | 7.276 | 1 | 1 | 7 |
GO:0000812 | Swr1 complex | 6.44e-03 | 1.00e+00 | 7.276 | 1 | 2 | 7 |
GO:0031122 | cytoplasmic microtubule organization | 7.35e-03 | 1.00e+00 | 7.083 | 1 | 2 | 8 |
GO:0042994 | cytoplasmic sequestering of transcription factor | 7.35e-03 | 1.00e+00 | 7.083 | 1 | 1 | 8 |
GO:0031011 | Ino80 complex | 7.35e-03 | 1.00e+00 | 7.083 | 1 | 2 | 8 |
GO:0005634 | nucleus | 8.11e-03 | 1.00e+00 | 1.226 | 7 | 67 | 3246 |
GO:0032886 | regulation of microtubule-based process | 8.27e-03 | 1.00e+00 | 6.914 | 1 | 2 | 9 |
GO:0008266 | poly(U) RNA binding | 8.27e-03 | 1.00e+00 | 6.914 | 1 | 1 | 9 |
GO:0006541 | glutamine metabolic process | 9.18e-03 | 1.00e+00 | 6.762 | 1 | 1 | 10 |
GO:0043968 | histone H2A acetylation | 9.18e-03 | 1.00e+00 | 6.762 | 1 | 2 | 10 |
GO:0008380 | RNA splicing | 9.45e-03 | 1.00e+00 | 3.717 | 2 | 7 | 165 |
GO:0007067 | mitotic nuclear division | 9.45e-03 | 1.00e+00 | 3.717 | 2 | 8 | 165 |
GO:0007020 | microtubule nucleation | 1.01e-02 | 1.00e+00 | 6.624 | 1 | 1 | 11 |
GO:0070935 | 3'-UTR-mediated mRNA stabilization | 1.01e-02 | 1.00e+00 | 6.624 | 1 | 2 | 11 |
GO:0045120 | pronucleus | 1.01e-02 | 1.00e+00 | 6.624 | 1 | 1 | 11 |
GO:0035267 | NuA4 histone acetyltransferase complex | 1.10e-02 | 1.00e+00 | 6.499 | 1 | 3 | 12 |
GO:0007095 | mitotic G2 DNA damage checkpoint | 1.19e-02 | 1.00e+00 | 6.383 | 1 | 1 | 13 |
GO:0005525 | GTP binding | 1.33e-02 | 1.00e+00 | 3.461 | 2 | 5 | 197 |
GO:0005737 | cytoplasm | 1.47e-02 | 1.00e+00 | 1.306 | 6 | 50 | 2633 |
GO:0022008 | neurogenesis | 1.47e-02 | 1.00e+00 | 6.083 | 1 | 1 | 16 |
GO:0043234 | protein complex | 1.50e-02 | 1.00e+00 | 3.369 | 2 | 8 | 210 |
GO:0006206 | pyrimidine nucleobase metabolic process | 1.56e-02 | 1.00e+00 | 5.996 | 1 | 2 | 17 |
GO:0006270 | DNA replication initiation | 1.56e-02 | 1.00e+00 | 5.996 | 1 | 4 | 17 |
GO:0005813 | centrosome | 1.60e-02 | 1.00e+00 | 3.322 | 2 | 8 | 217 |
GO:0071364 | cellular response to epidermal growth factor stimulus | 1.65e-02 | 1.00e+00 | 5.914 | 1 | 1 | 18 |
GO:0071339 | MLL1 complex | 1.65e-02 | 1.00e+00 | 5.914 | 1 | 2 | 18 |
GO:0033574 | response to testosterone | 1.65e-02 | 1.00e+00 | 5.914 | 1 | 1 | 18 |
GO:0000794 | condensed nuclear chromosome | 1.65e-02 | 1.00e+00 | 5.914 | 1 | 3 | 18 |
GO:0019901 | protein kinase binding | 1.81e-02 | 1.00e+00 | 3.225 | 2 | 11 | 232 |
GO:0043044 | ATP-dependent chromatin remodeling | 1.83e-02 | 1.00e+00 | 5.762 | 1 | 2 | 20 |
GO:0034080 | CENP-A containing nucleosome assembly | 1.83e-02 | 1.00e+00 | 5.762 | 1 | 2 | 20 |
GO:0017144 | drug metabolic process | 1.92e-02 | 1.00e+00 | 5.691 | 1 | 1 | 21 |
GO:0043967 | histone H4 acetylation | 2.01e-02 | 1.00e+00 | 5.624 | 1 | 2 | 22 |
GO:0005876 | spindle microtubule | 2.19e-02 | 1.00e+00 | 5.499 | 1 | 2 | 24 |
GO:0003730 | mRNA 3'-UTR binding | 2.28e-02 | 1.00e+00 | 5.440 | 1 | 2 | 25 |
GO:0031492 | nucleosomal DNA binding | 2.28e-02 | 1.00e+00 | 5.440 | 1 | 2 | 25 |
GO:0006271 | DNA strand elongation involved in DNA replication | 2.64e-02 | 1.00e+00 | 5.225 | 1 | 8 | 29 |
GO:0018107 | peptidyl-threonine phosphorylation | 2.64e-02 | 1.00e+00 | 5.225 | 1 | 2 | 29 |
GO:0021987 | cerebral cortex development | 2.73e-02 | 1.00e+00 | 5.177 | 1 | 2 | 30 |
GO:0043195 | terminal bouton | 2.82e-02 | 1.00e+00 | 5.129 | 1 | 1 | 31 |
GO:0015030 | Cajal body | 2.91e-02 | 1.00e+00 | 5.083 | 1 | 2 | 32 |
GO:0007595 | lactation | 2.91e-02 | 1.00e+00 | 5.083 | 1 | 2 | 32 |
GO:0000910 | cytokinesis | 3.00e-02 | 1.00e+00 | 5.039 | 1 | 1 | 33 |
GO:0048146 | positive regulation of fibroblast proliferation | 3.18e-02 | 1.00e+00 | 4.954 | 1 | 1 | 35 |
GO:0000226 | microtubule cytoskeleton organization | 3.27e-02 | 1.00e+00 | 4.914 | 1 | 2 | 36 |
GO:0040008 | regulation of growth | 3.36e-02 | 1.00e+00 | 4.874 | 1 | 2 | 37 |
GO:0035690 | cellular response to drug | 3.45e-02 | 1.00e+00 | 4.836 | 1 | 2 | 38 |
GO:0042995 | cell projection | 3.72e-02 | 1.00e+00 | 4.726 | 1 | 2 | 41 |
GO:0000079 | regulation of cyclin-dependent protein serine/threonine kinase activity | 3.72e-02 | 1.00e+00 | 4.726 | 1 | 2 | 41 |
GO:0005524 | ATP binding | 4.20e-02 | 1.00e+00 | 1.868 | 3 | 23 | 892 |
GO:0030097 | hemopoiesis | 4.34e-02 | 1.00e+00 | 4.499 | 1 | 3 | 48 |
GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding | 4.43e-02 | 1.00e+00 | 4.469 | 1 | 3 | 49 |
GO:0006310 | DNA recombination | 4.52e-02 | 1.00e+00 | 4.440 | 1 | 6 | 50 |
GO:0006334 | nucleosome assembly | 4.61e-02 | 1.00e+00 | 4.411 | 1 | 4 | 51 |
GO:0055086 | nucleobase-containing small molecule metabolic process | 4.61e-02 | 1.00e+00 | 4.411 | 1 | 5 | 51 |
GO:0032355 | response to estradiol | 5.13e-02 | 1.00e+00 | 4.251 | 1 | 1 | 57 |
GO:0007265 | Ras protein signal transduction | 5.31e-02 | 1.00e+00 | 4.201 | 1 | 3 | 59 |
GO:0007565 | female pregnancy | 5.75e-02 | 1.00e+00 | 4.083 | 1 | 2 | 64 |
GO:0000922 | spindle pole | 6.10e-02 | 1.00e+00 | 3.996 | 1 | 4 | 68 |
GO:0005200 | structural constituent of cytoskeleton | 6.10e-02 | 1.00e+00 | 3.996 | 1 | 2 | 68 |
GO:0006325 | chromatin organization | 6.27e-02 | 1.00e+00 | 3.954 | 1 | 3 | 70 |
GO:0001889 | liver development | 6.36e-02 | 1.00e+00 | 3.934 | 1 | 1 | 71 |
GO:0051726 | regulation of cell cycle | 6.53e-02 | 1.00e+00 | 3.894 | 1 | 2 | 73 |
GO:0001649 | osteoblast differentiation | 6.62e-02 | 1.00e+00 | 3.874 | 1 | 2 | 74 |
GO:0015630 | microtubule cytoskeleton | 6.71e-02 | 1.00e+00 | 3.855 | 1 | 2 | 75 |
GO:0005815 | microtubule organizing center | 6.88e-02 | 1.00e+00 | 3.817 | 1 | 1 | 77 |
GO:0005819 | spindle | 7.14e-02 | 1.00e+00 | 3.762 | 1 | 4 | 80 |
GO:0030529 | ribonucleoprotein complex | 7.31e-02 | 1.00e+00 | 3.726 | 1 | 4 | 82 |
GO:0006260 | DNA replication | 8.34e-02 | 1.00e+00 | 3.529 | 1 | 11 | 94 |
GO:0010467 | gene expression | 8.35e-02 | 1.00e+00 | 2.020 | 2 | 31 | 535 |
GO:0008017 | microtubule binding | 8.60e-02 | 1.00e+00 | 3.484 | 1 | 4 | 97 |
GO:0016887 | ATPase activity | 8.85e-02 | 1.00e+00 | 3.440 | 1 | 6 | 100 |
GO:0007507 | heart development | 9.36e-02 | 1.00e+00 | 3.356 | 1 | 1 | 106 |
GO:0046777 | protein autophosphorylation | 9.36e-02 | 1.00e+00 | 3.356 | 1 | 2 | 106 |
GO:0000790 | nuclear chromatin | 9.61e-02 | 1.00e+00 | 3.315 | 1 | 3 | 109 |
GO:0006397 | mRNA processing | 9.70e-02 | 1.00e+00 | 3.302 | 1 | 2 | 110 |
GO:0001666 | response to hypoxia | 1.02e-01 | 1.00e+00 | 3.225 | 1 | 1 | 116 |
GO:0016607 | nuclear speck | 1.07e-01 | 1.00e+00 | 3.153 | 1 | 3 | 122 |
GO:0004672 | protein kinase activity | 1.10e-01 | 1.00e+00 | 3.118 | 1 | 2 | 125 |
GO:0000082 | G1/S transition of mitotic cell cycle | 1.10e-01 | 1.00e+00 | 3.118 | 1 | 24 | 125 |
GO:0019904 | protein domain specific binding | 1.14e-01 | 1.00e+00 | 3.061 | 1 | 2 | 130 |
GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding | 1.24e-01 | 1.00e+00 | 2.934 | 1 | 2 | 142 |
GO:0007283 | spermatogenesis | 1.45e-01 | 1.00e+00 | 2.691 | 1 | 2 | 168 |
GO:0043025 | neuronal cell body | 1.47e-01 | 1.00e+00 | 2.666 | 1 | 3 | 171 |
GO:0000166 | nucleotide binding | 1.51e-01 | 1.00e+00 | 2.624 | 1 | 6 | 176 |
GO:0044822 | poly(A) RNA binding | 1.64e-01 | 1.00e+00 | 1.441 | 2 | 25 | 799 |
GO:0006357 | regulation of transcription from RNA polymerase II promoter | 1.72e-01 | 1.00e+00 | 2.418 | 1 | 1 | 203 |
GO:0006281 | DNA repair | 1.72e-01 | 1.00e+00 | 2.418 | 1 | 19 | 203 |
GO:0019899 | enzyme binding | 1.78e-01 | 1.00e+00 | 2.369 | 1 | 4 | 210 |
GO:0070062 | extracellular vesicular exosome | 1.81e-01 | 1.00e+00 | 0.988 | 3 | 43 | 1641 |
GO:0043231 | intracellular membrane-bounded organelle | 1.84e-01 | 1.00e+00 | 2.315 | 1 | 7 | 218 |
GO:0003723 | RNA binding | 2.06e-01 | 1.00e+00 | 2.135 | 1 | 11 | 247 |
GO:0005829 | cytosol | 2.18e-01 | 1.00e+00 | 0.865 | 3 | 58 | 1787 |
GO:0045893 | positive regulation of transcription, DNA-templated | 2.98e-01 | 1.00e+00 | 1.525 | 1 | 10 | 377 |
GO:0005794 | Golgi apparatus | 3.24e-01 | 1.00e+00 | 1.387 | 1 | 5 | 415 |
GO:0008270 | zinc ion binding | 5.02e-01 | 1.00e+00 | 0.578 | 1 | 7 | 727 |
GO:0044281 | small molecule metabolic process | 5.57e-01 | 1.00e+00 | 0.362 | 1 | 32 | 844 |
GO:0003677 | DNA binding | 6.01e-01 | 1.00e+00 | 0.196 | 1 | 18 | 947 |
GO:0006351 | transcription, DNA-templated | 6.50e-01 | 1.00e+00 | 0.012 | 1 | 9 | 1076 |
GO:0005886 | plasma membrane | 8.37e-01 | 1.00e+00 | -0.717 | 1 | 11 | 1784 |